Area of research
Pharmacology · Psychiatry and Mental health
Research interest
Research interests include Treatment of Major Depression, Tryptophan and brain disorders, Genetic Associations and Epidemiology, and Bipolar Disorder and Treatment.
Antidepressant Switching as a Proxy Phenotype for Drug Nonresponse: Investigating Clinical, Demographic, and Genetic Characteristics
Recommendations for defining treatment outcomes in major psychiatric disorders using real-world data
Local patterns of genetic sharing between neuropsychiatric and insulin resistance-related conditions
Insulin resistance and poorer treatment outcomes in depression: evidence from UK Biobank primary care data
Polygenic predisposition to transdiagnostic symptom dimensions and treatment outcomes across psychiatric disorders
Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder
Pharmacological treatments for psychotic depression: a systematic review and network meta-analysis
The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response?
Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis
A stratified treatment algorithm in psychiatry: a program on stratified pharmacogenomics in severe mental illness (Psych-STRATA): concept, objectives and methodologies of a multidisciplinary project funded by Horizon Europe
Multi-omics data integration methods and their applications in psychiatric disorders
Clinical insights into the cross-link between mood disorders and type 2 diabetes: A review of longitudinal studies and Mendelian randomisation analyses
Correlation between emotion dysregulation and mood symptoms of bipolar disorder: A systematic review and meta‐analysis
The Effects of CYP2C19 Genotype on Proxies of SSRI Antidepressant Response in the UK Biobank
The link between cognition and somatic conditions related to insulin resistance in the UK Biobank study cohort: a systematic review
Depression with atypical neurovegetative symptoms shares genetic predisposition with immuno-metabolic traits and alcohol consumption
UCL Discovery (University College London) 2022cited by 44position: last
The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries
Machine Learning Prediction of Comorbid Substance Use Disorders among People with Bipolar Disorder
Genetic and clinical characteristics of treatment-resistant depression using primary care records in two UK cohorts
Identifying the Common Genetic Basis of Antidepressant Response
Genetic underpinnings of sociability in the general population
A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response
Transcriptome-wide association study of treatment-resistant depression and depression subtypes for drug repurposing
Epigenetic Basis of Psychiatric Disorders: A Narrative Review
Melancholic features in major depression – a European multicenter study
Precision psychiatry in clinical practice
A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping
Genetics of Treatment Outcomes in Major Depressive Disorder: Present and Future
Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatment
Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study